December 03, 2022
3 min watch
Save
VIDEO: Netarsudil increases episcleral venous flow
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
CHICAGO — In this Healio Video Perspective from the AAO meeting, Osamah Saeedi, MD, discusses the effects of netarsudil on episcleral venous flow in subjects with ocular hypertension and glaucoma suspects.
According to Saeedi, the study showed significant increases in episcleral venous flow and diameter at 1 hour after treatment with Rhopressa (netarsudil ophthalmic solution 0.02%, Alcon/Aerie). These effects persisted at 1 week.
Published by:
Sources/Disclosures
Collapse
Source:
Saeedi O. Single-cell erythrocyte tracking in human subjects reveals increase in episcleral venous flow with netarsudil 0.02. Presented at: American Academy of Ophthalmology meeting; Sept. 30-Oct. 3, 2022; Chicago.
Disclosures:
Saeedi reports receiving research support from Aerie, Heidelberg Engineering and Vasoptic Medical.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.